Women’s Health is a $100 Billion Market-and growing
Table of Contents
A new report challenges the idea that investing in women’s health is a niche bet, revealing over $100 billion in realized exits and 27 “unicorn” companies already thriving in the space.
- Over $100 billion has already been returned to investors through exits in women’s health.
- there are currently 27 “unicorn” companies-privately held startups valued at over $1 billion-focused on women’s health.
- Nearly half of all women’s health exits have occurred in the last five years, signaling accelerating growth.
- Diagnostics is a key driver of success within the women’s health market.
Forget the outdated notion that women’s health is a small corner of the healthcare landscape.A recent report paints a dramatically different picture: a robust, rapidly expanding market attracting notable investment and delivering substantial returns.
Furthermore, the landscape is populated by 27 “unicorn” companies-privately held startups valued at over $1 billion-dedicated to women’s health.
where is the Investment going?
While reproductive health often dominates the conversation, the report reveals a broader range of investment hotspots. Oncology-cancer care-stands out as a particularly strong area, with successful exits from companies focused on breast cancer screening and treatment. Other notable areas include HPV screening, neonatal testing, and bone health.
Examples of successful exits include ine (2006,HPV screening),Cytech (HPV screening),Oncotype dx (breast cancer diagnostics),Ventana (oncology screening),and Hologic (oncology and bone health),which was taken private in 2025 for $18 billion. Neonatal testing company, had an IPO of $4.4 billion in 2025.
A Data-Driven Approach
To ensure credibility, the report’s authors meticulously compiled a database using PitchBook, a thorough source of funding and investment information, spanning from 2000 to 2025. They supplemented this data with press releases and insights from investors and colleagues in the field. The methodology included a clear definition of “women’s health,” encompassing conditions that exclusively, disproportionately, or differently affect women.
Jeter noted a surprising finding: diagnostics plays a crucial role in anchoring the women’s health market. “Diagnostics really anchor this field,” she said. “If you look at our healthcare and you look at our screening programs…two out of three are for women.”
Looking Ahead
The report’s findings offer a compelling message to entrepreneurs, investors, and healthcare providers: women’s health is not only a vital area of need but also a smart business opportunity. With proven returns, a growing number of successful companies, and increasing investor interest, the future looks bright for innovation in this critical field.
